Health policy: Me-too drugs with limited benefits-the tale of regorafenib for HCC

Bishal Gyawali, Vinay Prasad

Research output: Contribution to journal › Short survey › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Health policy: Me-too drugs with limited benefits-the tale of regorafenib for HCC'. Together they form a unique fingerprint.